Henry Schein Is Down 10%. What History Says Now

Henry Schein's 1,468-Day Drawdown Shrinks to 9.9%

Henry Schein, Inc. (HSIC) is down 9.9% from its all-time high as of June 24, 2026, having just exited the yellow zone after 1,468 days in drawdown. The Drawdown Severity Score™ has improved to 2.0, placing the stock in the green zone. In 44 comparable prior drops of 5% or more, the stock took an average of 186 days to recover.

The Recovery Milestone

Our data shows that the stock has successfully transitioned from the yellow zone to the green zone as of June 24, 2026. This zone change indicates that the Drawdown Severity Score™ has dropped to 2.0, reflecting a shift to a "Slightly Elevated" risk status. This shift represents a positive momentum change for the stock after a prolonged period of depressed pricing.

The stock closed at $82.82, narrowing its distance from the all-time high of $91.96. While the 1,468-day duration of this drawdown highlights a slow and extended recovery process, the move into the green zone indicates that selling pressure has moderated. This transition provides a clearer view of the asset's path toward potential full recovery.

Peak Severity and the Road to Recovery

The stock spent a prolonged period in the yellow zone, where the severity score indicated elevated drawdown risk. Grinding through 1,468 days of price depression tested investor patience as the stock struggled to reclaim its previous highs. This extended duration represents one of the longest modern drawdowns for the company.

Understanding where the stock stands on its timeline helps put this recovery into perspective. The transition to the green zone suggests that the downward cycle is losing momentum, allowing the price to stabilize.

What Changed: Fundamental and Business Drivers

The operational improvements driving this recovery are rooted in recent financial performance and strategic corporate actions. According to reports on the company's Q1 results, Henry Schein delivered an earnings beat that exceeded market expectations. This performance was supported by steady demand in the dental market and successful margin expansion initiatives.

A key component of this operational shift is the company's BOLD+1 acquisitions strategy. This initiative focuses on expanding the high-margin specialty product portfolio and scaling global dental distribution. By integrating these acquisitions, the company is actively working to diversify its revenue streams and reduce its reliance on lower-margin distribution activities.

Financial analysts have responded to these operational changes with positive adjustments. A recent upgrade from BTIG highlighted the strengthening of the dental market and expected margin improvements as key catalysts. Additionally, corporate disclosures show that an affiliate has proposed common stock resales via J.P. Morgan, indicating structured liquidity management as the company's financial outlook stabilizes.

How This Compares: Historical Recovery Patterns

To understand the significance of the current 9.9% drawdown, we must look at the historical behavior of the stock. Our data shows that the company has experienced 169 total drawdown events since 2006. The current metrics show a clear deviation from historical averages, illustrating the unique nature of this 1,468-day cycle.

The current drawdown of 9.9% is nearly double the historical average max drawdown of -5.2%. This increased depth explains why the recovery has taken 1,468 days, vastly exceeding the historical average duration of 55 days. When the stock drops 5% or more, which has occurred 44 times in its history, it typically takes an average of 186 days to recover, further emphasizing how extended the current cycle has been.

Valuation Context

As of 2026-06-24, our data shows a divergence between the stock's price drawdown and its historical valuation multiples. The Price-to-Sales (P/S) ratio stands at 0.69, placing it in the 33rd percentile of its own daily history since 2006-06-23, which is below its historical median of 0.75. Conversely, the EV-to-EBITDA (EV/EBITDA) ratio is 12.9, ranking in the 79th percentile of its daily record since 2006-06-23, positioning it above its historical median of 11.4.

Current Position and Risk Framing

Despite the positive transition to the green zone, the stock remains 9.9% below its peak of $91.96. The Drawdown Severity Score™ of 2.0 confirms that while the immediate risk of further deep decline has lessened, the asset is not entirely out of the woods. The long-term price depression of 1,468 days shows that structural recovery takes time.

Investors tracking the stock should balance the improving technical picture with the mixed valuation signals. The low P/S percentile suggests a moderate sales-based valuation relative to the past, while the elevated EV/EBITDA percentile reflects higher valuation relative to operating cash flows. This divergence highlights the importance of monitoring whether the company's margin expansion can support its higher enterprise value.

What's Next: Key Thresholds to Watch

To confirm a full recovery, the stock must close the remaining 9.9% gap and reclaim its all-time high of $91.96. A sustained move above this level would officially end the 1,468-day drawdown period. This milestone would mark a complete structural turnaround for the company.

Conversely, a reversal in operational momentum could push the stock back into the yellow zone. A drop in price that increases the current drawdown beyond 10% would likely trigger an increase in the severity score. Monitoring these key price levels will help investors assess whether the green zone transition is a permanent trend or a temporary pause in a longer cycle.